Cingulate Inc.

Last updated September 27, 2026

Organization details

Legal name
Cingulate Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Kansas City
Headquarters state / province
Kansas
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CING
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001862150
EIN
86-3825535

Board of directors

Chief executives

Shane J. Schaffer · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

1 of this board's directors also sit on 1 other board. 1 is in the same sector.

Network of Cingulate Inc.'s board connections Streamex Corp. Streamex Corp. Patrick Joseph Gallagher Patrick Joseph Galla... Cingulate Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$656,964
5 purchases by 5 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Mar 9, 2026 Callahan Jennifer L. Officer (EVP and CFO) Grant or award +15,329 — —
Mar 9, 2026 Shane J. Schaffer Director, Officer (Chief Executive Officer) Grant or award +6,862 — —
Mar 9, 2026 Brams Matthew Officer (EVP and Chief Medical Officer) Grant or award +4,526 — —
Mar 9, 2026 Patel Nilay Dahyabhai Officer (EVP, CLO and CCO) Grant or award +5,475 — —
Mar 9, 2026 Silva Raul R. Officer (EVP and CSO) Grant or award +4,526 — —
Mar 9, 2026 Callahan Jennifer L. Officer (EVP and CFO) Shares withheld for tax −6,427 — —
Mar 9, 2026 Shane J. Schaffer Director, Officer (Chief Executive Officer) Shares withheld for tax −2,959 — —
Mar 9, 2026 Brams Matthew Officer (EVP and Chief Medical Officer) Shares withheld for tax −1,025 — —
Mar 9, 2026 Patel Nilay Dahyabhai Officer (EVP, CLO and CCO) Shares withheld for tax −2,086 — —
Mar 9, 2026 Silva Raul R. Officer (EVP and CSO) Shares withheld for tax −1,828 — —
Feb 13, 2026 Thomas Jeffrey Hargroves Director Open-market purchase +97,276 $5.04 $490,271
Feb 6, 2026 Peter J. Werth Director Open-market purchase +19,455 $5.04 $98,053
Feb 6, 2026 Callahan Jennifer L. Officer (SVP and CFO) Open-market purchase +4,864 $5.04 $24,515
Feb 6, 2026 Shane J. Schaffer Director, Officer (Chief Executive Officer) Open-market purchase +6,809 $5.04 $34,317
Feb 6, 2026 Brams Matthew Officer (EVP and Chief Medical Officer) Open-market purchase +1,946 $5.04 $9,808

Organizations in the same sector, closest in location and size first.

Questions about Cingulate Inc.

Who is the CEO of Cingulate Inc.?

Shane J. Schaffer is Cingulate Inc.'s Chief Executive Officer.

How many directors are on Cingulate Inc.'s board?

Cingulate Inc.'s board has 10 directors: Bryan Jay Lawrence, Curtis Medeiros, Gregg Wm Givens, Jeffrey S. Ervin, John A. Roberts, Patrick Joseph Gallagher, Peter J. Werth, Scott Applebaum, Shane J. Schaffer and Thomas Jeffrey Hargroves.

Are Cingulate Inc. insiders buying or selling shares?

Over the last 12 months, Cingulate Inc. insiders bought $656,964 of shares in 5 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="cingulate-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.